CACEV T[au] - Search Results

Year	Number of Results
2001	3
2004	2
2005	3
2006	5
2007	1
2008	3
2009	1
2010	1
2012	2
2013	4
2014	4
2015	1
2016	1
2018	1
2019	1
2020	1
2021	1
2022	0

1

In reply.

Maurac I, Sabol M, Car D, Cacev T, Levanat S. Maurac I, et al. Among authors: cacev t. Int J Gynecol Pathol. 2013 Mar;32(2):177. doi: 10.1097/01.pgp.0000427319.75615.d7. Int J Gynecol Pathol. 2013. PMID: 23370659 No abstract available.

2

Inflammation-related cytokines and their roles in gastroenteropancreatic neuroendocrine neoplasms.

Herman Mahečić D, Cigrovski Berković M, Zjačić-Rotkvić V, Čačev T, Kapitanović S, Ulamec M. Herman Mahečić D, et al. Among authors: cacev t. Bosn J Basic Med Sci. 2020 Nov 2;20(4):445-450. doi: 10.17305/bjbms.2020.4471. Bosn J Basic Med Sci. 2020. PMID: 32156252 Free PMC article.

3

Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients.

Nikolic N, Radosavljevic D, Gavrilovic D, Nikolic V, Stanic N, Spasic J, Cacev T, Castellvi-Bel S, Cavic M, Jankovic G. Nikolic N, et al. Among authors: cacev t. Medicina (Kaunas). 2021 Oct 15;57(10):1108. doi: 10.3390/medicina57101108. Medicina (Kaunas). 2021. PMID: 34684145 Free PMC article.

4

New insights into the role of chronic inflammation and cytokines in the etiopathogenesis of gastroenteropancreatic neuroendocrine tumors.

Cigrovski Berkovic M, Cacev T, Catela Ivkovic T, Zjacic-Rotkvic V, Kapitanovic S. Cigrovski Berkovic M, et al. Among authors: cacev t. Neuroendocrinology. 2014;99(2):75-84. doi: 10.1159/000362339. Epub 2014 Mar 28. Neuroendocrinology. 2014. PMID: 24686050 Free article. Review.

5

Prothrombin 3'end Gene Variants in Patients With Sporadic Colon Adenocarcinoma.

Cumbo M, Tomic B, Dunjic S, Jovanovic T, Gvozdenov M, Pruner I, Aralica G, Kapitanovic S, Cacev T, Djordjevic V. Cumbo M, et al. Among authors: cacev t. Anticancer Res. 2019 Nov;39(11):6067-6071. doi: 10.21873/anticanres.13814. Anticancer Res. 2019. PMID: 31704834

6

Analysis of MSH2 Loss of Heterozygosity, Expression, and IVS10+12G>A Polymorphism in Sporadic Colon Cancer.

Cacev T, Zapletal E, Musani V, Rako I, Loncar B, Aralica G, Kapitanovic S. Cacev T, et al. Anticancer Res. 2018 May;38(5):2841-2848. doi: 10.21873/anticanres.12529. Anticancer Res. 2018. PMID: 29715107

7

TNFα gene/protein in tumorigenesis of sporadic colon adenocarcinoma.

Kapitanović S, Čačev T, Catela Ivković T, Lončar B, Aralica G. Kapitanović S, et al. Among authors: cacev t. Exp Mol Pathol. 2014 Oct;97(2):285-91. doi: 10.1016/j.yexmp.2014.08.003. Epub 2014 Aug 4. Exp Mol Pathol. 2014. PMID: 25102301

8

miR-106a overexpression and pRB downregulation in sporadic colorectal cancer.

Catela Ivkovic T, Aralica G, Cacev T, Loncar B, Kapitanovic S. Catela Ivkovic T, et al. Among authors: cacev t. Exp Mol Pathol. 2013 Feb;94(1):148-54. doi: 10.1016/j.yexmp.2012.11.002. Epub 2012 Nov 23. Exp Mol Pathol. 2013. PMID: 23178825

9

Loss of NF2/Merlin expression in advanced sporadic colorectal cancer.

Cačev T, Aralica G, Lončar B, Kapitanović S. Cačev T, et al. Cell Oncol (Dordr). 2014 Feb;37(1):69-77. doi: 10.1007/s13402-013-0164-2. Epub 2013 Dec 10. Cell Oncol (Dordr). 2014. PMID: 24323642

10

High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

Cigrovski Berković M, Čačev T, Catela Ivković T, Marout J, Ulamec M, Zjačić-Rotkvić V, Kapitanović S. Cigrovski Berković M, et al. Among authors: cacev t. Mol Cell Endocrinol. 2016 Apr 15;425:61-8. doi: 10.1016/j.mce.2016.01.013. Epub 2016 Jan 19. Mol Cell Endocrinol. 2016. PMID: 26805636

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results